Exclusive: ASA calls number of parallel probes ‘significant’ and describes tackling issue as ‘priority’ after it issued ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...

Outside the game, commercials are a big part of Super Bowl Sunday. Companies pay large amounts of money for their ...

Novo Nordisk also sells semaglutide as Ozempic for diabetes in the UK ... and is currently available in the original singe-dose pen-injector format. Mounjaro has already been launched in other ...

Super Bowl commercial, telehealth company Hims & Hers takes aim at the obesity epidemic and critiques America's healthcare ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut ...

Symptoms of NAION can include blurred vision, peripheral vision loss, dark spots in vision, and changes in color perception. Though the exact mechanism is not fully understood, researchers hypothesize ...